chrisvoncsefalvay/vaers-outcomes huggingface dataset:
first dose on 2019/Inappropriate schedule ofvaccine; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 17th May 2019).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. The patient received their first dose of Shingrix on at a different facility. Till the time of reporting, the patient did not receive the 2nd dose of Shingrix, which led to incomplete course of vaccination. The reporter did not consent to follow-up. The reporter declined to provide additional information, both due to time constraints and lack of additional information.
Shingles in the eye; Severe heal pain; Vomit; fatigue; chills; diarrhea; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DIARRHOEA (diarrhea), HERPES ZOSTER (Shingles in the eye), PAIN IN EXTREMITY (Severe heal pain), VOMITING (Vomit) and FATIGUE (fatigue) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M20A and 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Feb-2021, the patient experienced DIARRHOEA (diarrhea), VOMITING (Vomit), FATIGUE (fatigue) and CHILLS (chills). On an unknown date, the patient experienced HERPES ZOSTER (Shingles in the eye) and PAIN IN EXTREMITY (Severe heal pain). The patient was treated with ACYCLOVIR [ACICLOVIR] for Shingles, at a dose of 1 dosage form. On 25-Feb-2021, DIARRHOEA (diarrhea), VOMITING (Vomit), FATIGUE (fatigue) and CHILLS (chills) had resolved. At the time of the report, HERPES ZOSTER (Shingles in the eye) and PAIN IN EXTREMITY (Severe heal pain) outcome was unknown.            No concomitant medication was reported.   This case was linked to MOD-2021-273282 (Patient Link).
I was feeling unwell, did not move off the couch. I decided to test for COVID using a home COVID-19 test it came back positive. I called the doctor's office, they advised me not to come in, prescribed me PAXLOVID that I started immediately. I am feeling much better now. Thankfully I did not get rebound.
Worsened, severe post-herpetic neuralgia in prior T1-T2 distribution.  Starting on treatment with gabapentin and topical lidocaine.
Information was received from the authoers published literature, concerning a female child (age unknown). On an unknown date when the patient was a child, she was vaccinated with a dose of M-M-R II (dose and route unspecified). Although she had been vaccinated her measles antibody index (AI) was 0.7 (negative) when she was approximately 26 year old. Then she was vaccinated again with M-M-R II (dose and route unspecified). Her measles index 8 weeks after receiving M-M-R II was 2.06 (positive). The outcome of the event was considered as recovered on an unknown date. This is one of several reports received from the same source (linked with MARRS# 1602USA009550). Additional information has been requested.
Pt called the same day after receiving the vaccine in the morning complaining of symptoms of swelling in left arm above and below the place the vaccine was administered.
Severe random pain in right shoulder radiates down to hand and up into neck.  Numbness and tingling in arm down to and including fingers
MESSED UP / SLURRED SPEECH; HAND PAIN LIKE HITTING A NERVE; FELT TIRED; STROKE; FEELING REALLY HOT; NECK PAIN FOR 4 HOURS; This spontaneous report received from a patient concerned a 60 year old female of unspecified race and origin. The patient's height, and weight were not reported. The patient's concurrent conditions included: Non-smoker, and other pre-existing medical conditions included: The patient was healthy.  The patient work and exercise. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown, Expiry: Unknown) dose, 1 total administered, start therapy date were not reported (3 to 4 months ago) for prophylactic vaccination. The batch number was not reported and has been requested. Concomitant medications included covid-19 vaccine for prophylactic vaccination which the patient mentioned taking after JANSSEN Vaccine. On JUN-2021, the patient experienced stroke, feeling really hot, neck pain for 4 hours, hand pain like hitting a nerve and felt tired. The patient took medical attention for it but only they treated her hand pain and referred her to a hospital which she refused to do. On AUG-2021, the patient experienced messed up / slurred speech. The patient  refused and said ,she did not want to go to a doctor or hospital because she might get more sick (she mentioned Covid in her area was bad).  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from feeling really hot, neck pain for 4 hours, and felt tired, and the outcome of messed up / slurred speech, hand pain like hitting a nerve and stroke was not reported This report was serious (Other Medically Important Condition).; Sender's Comments: V0.20210841218-covid-19 vaccine ad26.cov2.s -Stroke. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Fever; chills; muscle aches; pain at injection site; headache; chest pain; This is a spontaneous report from a contactable nurse (patient). A 35-year-old female patient received 2nd dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot# EK9231), via an unspecified route of administration in right arm on 12Jan2021 at single dose for covid-19 immunisation. Medical history included sulfa allergy, canteloupe allergy. The patient's concomitant medications were not reported. No any other medications the patient received within 2 weeks of vaccination. The patient previously received 1st dose of BNT162B2 (lot# EJ1685) via intramuscular in right arm on 22Dec2020 13:00 for covid-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced fever, chills, muscle aches, pain at injection site, headache, chest pain on 12Jan2021 17:00. The patient was not pregnant. No treatment received for the events. The outcome of events was recovered on an unspecified date of Jan2021. This case was reported as non-serious. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.
Systemic: Allergic: Difficulty Breathing-Severe, Additional Details: Husband came into pharmacy to get his second dose, reported wife recieved vaccine on 10/18/21 and died on 10/20/2021. Woke up with difficulty breathing, took patient to ER. Previous medical conditions HTN, prediabetic, already on oxygen. Husband unsure if vaccine caused rapid decline or caused, but wanted to report. When got to ER patient was found to have AFib.
Muscle soreness localized to injection sight (right deltoid) which developed approximately 6 hours after vaccination was administered. Nausea and fatigue which developed approximately 3.5 hours after vaccination was administered and has persisted into the next day.
experience redness; swelling; shortness of breath; This case was reported by a consumer via call center representative and described the occurrence of erythema in a 49-year-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVA175A, expiry date 31st July 2020) for prophylaxis.   On 14th January 2020, the patient received Menveo. On 14th January 2020, couple of hours after receiving Menveo, the patient experienced erythema, swelling and shortness of breath. On an unknown date, the outcome of the erythema, swelling and shortness of breath were unknown.   It was unknown if the reporter considered the erythema, swelling and shortness of breath to be related to Menveo.  Additional details were received as follows: The reporter stated that the patient few hours after vaccination experienced redness, swelling, and shortness of breath and the patient was taken to the emergency room. The reporter was not aware if the patient had received previous doses of Menveo vaccine before. The reporter consented to follow up.
Starting 01/03/2023, I woke up with a fever and, since that was unusual for me, I was concerned and I took 2 at-home COVID-19 tests which were both negative. I went to urgent care and they felt I had a virus, so they did a flu test and a COVID-19 test. The next day, my symptoms had worsened and the doctor called me back to let me know I was positive for COVID-19. She prescribed PAXLOVID for me and I was unable to start it until that Saturday, 01/07/2023, due to being out of stock at my pharmacy and needing to order it. I started feeling better before I started the PAXLOVID and wasn't sure if I should take it but my mother convinced me otherwise. The bad symptoms lasted until about Saturday (coughing and runny nose). The fever finally went away yesterday and I have a mild sinus headache. The runny nose has stopped and the fatigue has mostly resolved.
Tightness in chest, "difficulty breathing," which was present in the evening but resolved in the morning.  In the evening she also began developing pruritus over her entire body and small bumps where she feels the pruritus.
ARM SORENESS; HEADACHE; This spontaneous report received from a consumer concerned an 86 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 31-MAR-2021 for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On 31-MAR-2021, the patient experienced arm soreness. On 31-MAR-2021, the patient experienced headache. The action taken with covid-19 vaccine  was not applicable. The patient recovered from headache on 03-APR-2021, and was recovering from arm soreness. This report was non-serious. This case, from the same reporter is linked to 20210840400.
fatigue 3 hours afterwards; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 56-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 19Sep2022 as dose number unkown (booster), single (Batch/Lot number: unknown) at the age of 56 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary immunization Series completed, Unknown manufacturer), for Covid-19 immunization. The following information was reported: FATIGUE (non-serious) with onset 19Sep2022, outcome "not recovered", described as "fatigue 3 hours afterwards". Additional information: Patient reported that he received the bivalent booster of the Pfizer COVID-19 vaccine on 19Sep2022. He began experiencing fatigue 3 hours afterwards and it was persisting. Caller would like to know how long that fatigue will last.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
This spontaneous report as received from a medical assistant refers to an unspecified number of patients of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical histories provided. On unknown dates, the patients were vaccinated with improperly stored doses of PROQUAD lot # L023112, expiration date 24-DEC-2016; lot # L041627, expiration date 20-APR-2017; lot # L047305, expiration date 23-MAY-2017; lot # M002058, expiration date 11-JUL-2017; lot # M018638, expiration date 11-OCT-2017 (dose and route of administration were not reported). There was no adverse effect reported. Administered doses of vaccines experienced the temperature excursion of -9.9 degrees Celsius for 14 hours. There were previous excursions of -11 degrees Celsius for 4 hours, -13.1 degrees Celsius for 5 days, -13.6 degrees Celsius for 14 days, -12 degrees Celsius for 2 days, -13.9 degrees Celsius for 3 days, -13.1 degrees Celsius for 5 days, -13 degrees Celsius for 7 days, -11.1 degrees Celsius for 2 days, -12.2 degrees Celsius for 9 days, -14 degrees Celsius for 9 days, -11.1 degrees Celsius for 1 day, -12.8 degrees Celsius for 10 days, -14.6 degrees Celsius for 1 day, -14.2 degrees for 4 days, -14.6 degrees Celsius for 1 day, -14.8 degrees Celsius for 3 days, -14 degrees Celsius for 10 days, -13.7 degrees Celsius for 1 day. This is one of several reports received from the same reporter. Additional information has been requested.
Joint, muscle, nerve pain that did not go away.  Brain fog, and extreme fatigue.  So difficult to even get out of bed every day.  But even laying in bed I can feel my body aching and burning.
admitted to the hospital 4.5 weeks after second vaccine dose with hypotension, fever, diarrhea, pancytopenia. Ultimately diagnosed with hemophagocytic lymphohistocytosis (HLH).
One day after KINRIX injection pain (L) arm (site of injection) 8 hrs later swelling, redness tenderness (L) upper arm past elbow which increased over 24 hrs esp with use of (L) arm child seen today in office with upper arm to upper forearm moderate swelling redness.
Pt stated prior to vaccination that he gets dizzy often with injections. Pt immediately lost consciousness after injection. Two nurses lowered him to the floor, no injuries were sustained. Recovered consciousness within one minute. Could state name and that he had no other signs or symptoms beyond dizziness. Given Gatorade and observed for 15 minutes with no additional symptoms.
Fever 5/8-5/12; Developed a rash on 5/12/19; Dx as viral rash.
This medically confirmed report (initial receipt 22-Jan-2013) concerns a female patient, age unspecified. Years ago the patient received a flu vaccine (manufacturer and batch number not specified) and developed a severe reaction. She was almost in a coma. She sought medical attention, details of which were not provided. The outcome was reported as recovered.
Patient received SHINGRIX and PREVNAR 13 on 3/38/18. Next day pt felt "exhausted", had severe itching on back between shoulder blades and upper torso between breasts. Had slight headache and muscle pain. Visible rash on torso.
Pt received varicella injection at 11:55. Within 5 minutes from varicella injection pt developed reddened area at injection site and reddened induration 2 cm distal injection site. Ice applied to area for 20 minutes and redness and swelling decreased. No other symptoms noted. Pt discharged to home. Spoke with pt's mom at 14:00, redness and induration improving when pt left clinic.
Vaccine was given after it had unknowingly experienced a temperature excursion that rendered it not suitable per use per the manufacturer. No adverse event occurred that we know of.
Pt recvd vax & a few minutes later had BP of 160/110, numbness around hands, slurred speech, & weak nervous; pt seen in ER;
Pt to ED 9/10 for  unintentional left arm contractions after fall. 9/13 pt Hypertensive and bradycardic. 9/14 pt COVID+, rx remdesivir for 3 days, no alleviating or aggravating factors. 9/16 no new complaints noted; stable; no acute cardiac issues noted. 9/18 pt to OR for brain biopsy. 9/19 pt A&OX4, VSS, Patient has no complaints of pain. 9/20 no overnight issues, pt feeling better. 9/23 pt discharged.
Felt itching at injection site. Sunday there was lump and redness; Monday spreading redness, Tuesday lump started moving down arm, Wed lump moving toward elbow, area very warm. Returned to doctor, doctor prescribed antibiotic for 10 days (cephalexin).  Thursday still very warm, lump moving toward elbow, redness spreading.  Since then lump went down, redness has decreased, warmness decreased.  Redness almost gone as of 10/13/2013.
Patient was given Menveo injection by mistake. Provider notified, parent notified as well as patient. Agreed that no adverse issue if correct Bexero injection would be given. Parental permission to give Bexero, patient tolerated without issue.
This is spontaneous report received from contactable consumer. A female patient of an unspecified age received the second dose of BNT162B2 (COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced chills, throwing up, can't move, everything hurts on 05Apr2021. The reporter was calling for her sister and she has got every symptom yesterday (05Apr2021) after getting the second shot. The patient had chills, throwing up, can't move, everything hurts, and just every single thing from the list. The reporter was asking is this normal having all these at the same time. The reporter was thinking if her sister had the vaccine and has such a reaction can she get an antibody infusion. The patient had a list of symptoms and checked them off and she has all of them. The reporter is wondering if her sister is a candidate if she got the vaccine and not like it's a live vaccine, she knew that, but would antibody therapy be good for her and she doesn't know what to do she felt helpless. Caller stated she knew these are side effects. The outcome of the events was unknown. No Follow-up attempts are needed. No further information is expected. Information about lot/batch number cannot be obtained.
Onset of dry cough, moderate chest congestion, afternoon fatigue, and mild sore throat 1 day after receiving 2nd dose of Pfizer COVID-19 vaccination on 01-May (8 days now).
Daughter started with severe stomach cramps..  said she wanted to throw up.  Was rolling around and crying in pain.  She felt hot but I didn?t have thermometer and she was sweating.  Her upset stomach lasted all until the next morning.  Called and left voicemail to doctors office we will not be taking shot 2 of Meningitis B
Patient reported wide spread itching all over body 15 minutes after vaccination. State that she had a history of this type of reaction at least once a year and it is usually relieved by Benadryl. Was given 50 mg of Benadryl and symptoms resolved.
Pinkness at the injection site; Bump at the injection site; Pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOLOURATION (Pinkness at the injection site), VACCINATION SITE PAIN (Pain at the injection site) and VACCINATION SITE SWELLING (Bump at the injection site) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced VACCINATION SITE PAIN (Pain at the injection site). On an unknown date, the patient experienced VACCINATION SITE DISCOLOURATION (Pinkness at the injection site) and VACCINATION SITE SWELLING (Bump at the injection site). On 24-Feb-2021, VACCINATION SITE PAIN (Pain at the injection site) had resolved. At the time of the report, VACCINATION SITE DISCOLOURATION (Pinkness at the injection site) and VACCINATION SITE SWELLING (Bump at the injection site) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant Medications were  provided by Reporter. No Treatment Medications were  provided by Reporter.
Pain at injection site Diffuse severe myalgias Migraine headache Fatigue to the point that I had to leave work early and take a nap which is unusual  All symptoms began at the same time and are still present now 36 hours after getting this vaccine
Body aches, chills, fever, swollen lymph node in right arm (side of injection)
Fever, UrticariaPruritus, Induratin at injection site Narrative:
7/1/22 at (0800) Patient emailed today to report he had a reaction to his MMR vaccine given in clinic earlier this week. I left a message for him to call back to provide more information as to what symptoms he was having with his reaction? Directed patient to contact company to make an appointment to be assessed. Notified company via email to let them know patient may call to schedule a visit today.   7/1/22 at (1445) Patient stopped by clinic, asked if he received my emails and phone message. He reports he did not receive any messages today. His right Lateral upper arm appeared pink in color w/ an approximate 2.5-3 inch rash like area. He reports he went to a local urgent care yesterday on 6/30/22. He was directed to take ibuprofen for the discomfort, but no further treatment was ordered. He did not appear short of breath or in any distress. I asked the pt to please contact company as previously instructed this morning per messages as there is a provider available if need to be further assessed. He agreed to call and see them today.
Patient experienced significant nausea and vomiting and 103 degree fever.  Symptoms started about 4 hours after vaccination and built for the next 3 hours before patient went to the emergency room for treatment.
Red, itchy, hot rash on my arm at the injection site that lasted for a few days.
About 30 seconds after completing vaccinations, patient experienced a loss of consciousness with seizure-like activity. Episode lasted 20-30 seconds, and patient returned to baseline within 10 seconds.
L leg 5" x 6" warm, red raised area. Zyrtec 21 daily.
Headache, Nausea, Stomach Pain, Chills; took Motrin 800 mg prn; all next day lightheaded and weak.
Headache began 6 hours after vaccine; headache became worse and fever onset. Fever was 101F at 12 hours post-vaccine. Chills, sweating, severe fatigue, and headache persisted for 2 days post-vaccine.
Moderna COVID-19 Vaccine EUA Bad rash all over my body.  Severe itching. Zyrtec and Pepcid.  Just started 02/11/2021